TransMedics Group 股价上涨 19%，第四季度收入增长 159% 至 8120 万美元，全年收入达到 2.416 亿美元。 TransMedics Group shares rose 19% after Q4 revenue increased 159% to $81.2m and full-year revenue reached $241.6m.
TransMedics Group 公布第四季度收入增长 159% 至 8120 万美元，全年收入增长至 2.416 亿美元，股价上涨 19%。 TransMedics Group shares rose 19% after reporting a 159% increase in Q4 revenue to $81.2m and full-year revenue to $241.6m. 该公司第四季度实现净利润 400 万美元，较去年第四季度 670 万美元的净亏损大幅改善。 The company achieved a net income of $4.0m in Q4, significantly improving on a net loss of $6.7m in Q4 of the previous year. 该公司预计 2024 年收入将在 3.6 亿美元至 3.7 亿美元之间，增幅为 49% 至 53%，截至 2023 年 12 月 31 日，现金状况强劲，为 3.948 亿美元。 The company anticipates revenue between $360m and $370m for 2024, representing 49% to 53% growth, with a strong cash position of $394.8m as of December 31, 2023.